TransMedics Other Current Liab Over Time
| TMDX Stock | USD 87.11 6.50 8.06% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out TransMedics Performance and TransMedics Correlation. TransMedics |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TransMedics. If investors know TransMedics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TransMedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.93 | Revenue Per Share 12.157 | Quarterly Revenue Growth 0.637 | Return On Assets 0.0284 | Return On Equity 0.1941 |
The market value of TransMedics Group is measured differently than its book value, which is the value of TransMedics that is recorded on the company's balance sheet. Investors also form their own opinion of TransMedics' value that differs from its market value or its book value, called intrinsic value, which is TransMedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TransMedics' market value can be influenced by many factors that don't directly affect TransMedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TransMedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if TransMedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TransMedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Current Liab Analysis
Compare TransMedics Group and related stocks such as Inspire Medical Systems, Inari Medical, and InMode Other Current Liab Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INSP | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 4.1 M | 7.7 M | 12.4 M | 13.5 M | 20.1 M | 33 M | 39.3 M | 41.2 M |
| NARI | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 6.3 M | 10.8 M | 34.4 M | 45.9 M | 62.4 M | 65.5 M |
| INMD | 2.6 M | 2.6 M | 2.6 M | 2.6 M | 2.6 M | 2.6 M | 2.6 M | 6.2 M | 18.8 M | 12.5 M | 15.1 M | 26.8 M | 31.3 M | 34.9 M | 20.4 M |
| PODD | (11 K) | 931 K | 19.1 M | 19.5 M | 24.7 M | 42.1 M | 41 M | 59.3 M | 89 M | 96.4 M | 132.7 M | 162.5 M | 306.4 M | 382.6 M | 401.7 M |
| LUNG | 5.9 M | 5.9 M | 5.9 M | 5.9 M | 5.9 M | 5.9 M | 5.9 M | 5.9 M | 5.9 M | 10.9 M | 6.4 M | 13.4 M | 10 M | 13.2 M | 11 M |
| OFIX | 1.7 M | 54 M | 47 M | 49.4 M | 53.2 M | 65.6 M | 69.1 M | 61.3 M | 67.9 M | 64.7 M | 72.7 M | 70.3 M | 47.1 M | 93.8 M | 98.5 M |
| TELA | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 6.1 M | 3.5 M | 6 M | 8.2 M | 10.5 M | 14.7 M | 8 M |
| CVRX | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 7.5 M | 5 M | 6 M | 5.6 M | 5.2 M |
| NPCE | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 6.6 M | 7.9 M | 6 M | 9.5 M | 7.6 M |
| DCTH | 110 K | 2.4 M | 3.4 M | 2.3 M | 3.8 M | 6 M | 22.1 M | 4 M | 4.6 M | 3.4 M | 4.7 M | 4.1 M | 4.5 M | 5.2 M | 6.4 M |
| PEN | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 16.9 M | 25.1 M | 31.3 M | 44.8 M | 57.9 M | 4.3 M | 79.8 M | 89.8 M | 85.2 M | 103.6 M | 55.2 M |
| MASI | 1.5 M | 32.6 M | 43.2 M | 54.9 M | 64.7 M | 85.4 M | 151 M | 81.9 M | 24.6 M | 87.1 M | 141.8 M | 155.4 M | 247 M | 188.1 M | 197.5 M |
TransMedics Group and related stocks such as Inspire Medical Systems, Inari Medical, and InMode Other Current Liab description
My Equities
My Current Equities and Potential Positions
| TransMedics Group | TMDX |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
USD 87.11
Additional Tools for TransMedics Stock Analysis
When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.